Cartilage Recovery in Adults With Knee Osteorthritis by Mesenchymal Cell Therapy: Randomized Trial of Radiologic and Clinical Outcomes

Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age40-60
SponsorGUSTAVO SALGUERO

About this trial

The treatment of osteoarthritis (OA) of the knee remains still controversial. Despite that fact advanced stages with symptomatic and functional improvement are obtained with total knee replacement, however, there is no treatment that neither modifies the natural history of this disease, nor avoid joint replacement surgery in young patients in whom the prosthesis has conflictive indications. Moreover, prosthetic surgery leads to lower long-term survival and in older patients, higher morbidity and mortality. Cell therapy promises to be a treatment option through the use of mesenchymal cells with the capacity control inflammatory responses and trigger the differentiation into chondrocytes. Here we propose a randomized placebo-controlled clinical trial to evaluate radiologic and clinical outcomes in patients with knee OA.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • INMUNOCEM
  • PLACEBO COMPARATOR

Treatment groups

32 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

GUSTAVO SALGUERO

Lead sponsor

Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud - IDCBIS

Sponsor institution

Hospital Infantil Universitario de San Jose

Collaborator